Form 4 holding
Head of R&D
Neumora Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 309,092
- Estimated value
- $516,616
- Report date
- 18 Feb 2025
- Price
- $1.67
- Ownership
- Direct
Robert A. Lenz - Head of R&D at Neumora Therapeutics, Inc.
Issuer-level insider activity
- Role
- Head of R&D
- Issuer ticker
- NMRA on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
No buys or sells have been reported by Robert A. Lenz since 28 Aug 2025
Reported holdings for Robert A. Lenz in Neumora Therapeutics, Inc.
Form 4 holding
Head of R&D
Neumora Therapeutics, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 100,000
- Estimated value
- Report date
- 13 Feb 2025
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Robert A. Lenz in Neumora Therapeutics, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.